Published in J Obstet Gynaecol India on November 05, 2014
Why consider vaginal drug administration? Fertil Steril (2004) 2.54
Luteal phase support. Fertil Steril (2002) 2.20
Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation. Fertil Steril (2008) 1.80
Assisted reproductive technology surveillance -- United States, 2010. MMWR Surveill Summ (2013) 1.64
Early progesterone cessation after in vitro fertilization/intracytoplasmic sperm injection: a randomized, controlled trial. Fertil Steril (2012) 1.49
Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev (2011) 1.48
Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles. Fertil Steril (1999) 1.24
An update of luteal phase support in stimulated IVF cycles. Hum Reprod Update (2007) 1.22
Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil Steril (1994) 1.21
Hormonal induction of endometrial receptivity. Fertil Steril (2011) 1.19
Direct transport of progesterone from vagina to uterus. Obstet Gynecol (2000) 1.16
Targeted drug delivery in gynaecology: the first uterine pass effect. Hum Reprod (1997) 1.01
Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol. Hum Reprod (1992) 1.00
Transvaginal administration of progesterone. Obstet Gynecol (1997) 0.96
Luteal support: progestogens for pregnancy protection. Maturitas (2009) 0.96
The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril (1994) 0.94
The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix. Fertil Steril (1998) 0.91
Preparation of endometrium for egg donation. Hum Reprod Update (1999) 0.90
Progesterone vaginal ring versus vaginal gel for luteal support with in vitro fertilization: a randomized comparative study. Fertil Steril (2013) 0.89
Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Hum Reprod (1990) 0.87
Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study. Fertil Steril (1999) 0.87
Human luteal phase function following oocyte aspiration from the immediately preovular graafian follicle of spontaneous ovular cycles. Br J Obstet Gynaecol (1981) 0.86
Evaluation of an optimal luteal phase support protocol in IVF. Acta Obstet Gynecol Scand (2001) 0.86
Luteal support after in-vitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone. Hum Reprod (1996) 0.82
Luteal phase support for frozen embryo transfer cycles: intramuscular or vaginal progesterone? Fertil Steril (2014) 0.80
Vaginal delivery of progesterone in donor oocyte therapy. Hum Reprod (2000) 0.80
Prospective randomized trial to evaluate the efficacy of a vaginal ring releasing progesterone for IVF and oocyte donation. Hum Reprod (2000) 0.78
Pilot study evaluating a progesterone vaginal ring for luteal-phase replacement in donor oocyte recipients. Fertil Steril (2008) 0.77